1. Nora D. Volkow >> 
    MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH)
  2. Patrick G. O’Connor >>
    MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine
  3. Þórarinn Tyrfingsson
    MD, past Medical Director at SÁÁ
  4. Kaarlo Simojoki >>
    MD, PhD, Chief Medical Officer of the A-Clinic Foundation
  5. David R. Gastfriend >>
    M.D. Chief Architect, CONTINUUM – The ASAM Criteria Decision Engine TM Chief Medical Officer & Co-Founder, DynamiCare Health, Inc. Scientific Advisor, Treatment Research Institute
  6. Andrew H. Talal >>
    MD, MPH, School of Medicine and Biomedical Sciences, University at Buffalo, New York
  7. Jeffrey Goldsmith >>
    MD, DLFAPA, DFASAM, past president of ASAM
  8. Paul Earley >>
    MD, DFASAM, Medical Director of the Georgia Professionals Health Program, in the U.S.
  9. Valgerður Rúnarsdóttir >>
    MD, Medical Director of SÁÁ
  10. Stephen Strobbe >>
  11. Gerard J. Schmidt >>
    President, NAADAC, The Association for Addiction Professionals
  12. Thomas Clausen Professor >>
    Dr. Med, University of Oslo
  13. Kári Stefánsson >>
    MD, Decode Genetics
  14. Thorgeir Thorgeirsson
    PhD, Decode Genetics
  15. Frank J. Vocci >>
    PhD, President, Friends Research Institute
  16. Judith A. Aberg >>
    MD, FIDSA, FACP, Professor of Medicine, Chief, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai
  17. Erna Milunka Kojic
    MD, professor at Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai
  18. Sigurður Ólafsson >>
    MD, FACP, Director of Hepatology, Division of Gastroenterology, Department of Medicine Landspitali University Hospital
  19. Josiah D. Rich >>
    MD, MPH, Professor of Brown University, RI
  20. George Woody >>
    MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania
  21. Arndís Sue Ching Löve >>
    PhD student MS Pharm
  22. Jag Khalsa >>
    MS, PhD, Chief, Medical Consequences Branch Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, NIH
  23. Gregory Bunt >>
    MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY